FRESENIUS SE+CO.KGAA O.N.

Premiumpartner

Firmenbeschreibung

Die Fresenius SE ist ein international tätiger Gesundheitskonzern, der Produkte und Dienstleistungen für Krankenhäuser, die ambulante medizinische Versorgung von Patienten und die Dialyse anbietet. Weitere Arbeitsfelder sind das Krankenhausträgergeschäft sowie Engineering- und Dienstleistungen für verschiedene Gesundheitseinrichtungen. Zum Fresenius-Konzern gehören vier Unternehmen, die weltweit eigenverantwortlich wirtschaften und handeln: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios und Fresenius Vamed. Fresenius Medical Care ist der weltweit führende Anbieter von Produkten und Dienstleistungen für Patienten mit chronischem Nierenversagen. Fresenius Kabi ist Marktführer in der Infusionstherapie und in der klinischen Ernährung in Europa. Die Helios Kliniken Gruppe ist eines der größten und medizinisch führenden Klinikunternehmen Europas und auf den Betrieb und das operative Management von Krankenhäusern spezialisiert. Vamed ist weltweit im Projekt- und Managementgeschäft von Gesundheitseinrichtungen tätig. Dazu zählen Krankenhäuser, Gesundheitszentren sowie Thermen- und Wellnesscenter. Darüber hinaus werden über die Fresenius NetCare Dienstleistungen im Bereich Informationstechnologie angeboten.

KeyData

endOfFinancialYear: 31.12.2022 01:00
stockholderStructure: Freefloat (61.22%),Else Kröner-Fresenius-Stiftung (26.33%),Harris Associates Investment Trust (5.02%),BlackRock, Inc. (4.99%),Amundi S.A. (2.44%)
sharesOutstanding: 563237277.0000
ceo: Michael Sen
board: Sara Hennicken, Pierluigi Antonelli , Robert Möller, Michael Moser
supervisoryBoard: Wolfgang Kirsch, Prof. Dr. D. Michael Albrecht, Stefanie Balling , Bernd Behlert , Michael Diekmann , Grit Genster , Konrad Kölbl , Frauke Lehmann , Prof. Dr. med. Iris Löw-Friedrich , Oscar Romero de Paco , Susanne Zeidler , Dr. Christoph Zindel , Holger Michel
countryID: 2
freeFloat: 56.4900
faceValue: 1.0000
faceValueCurrencyID: 1
faceValueCurrency: EUR
sectorName: Medizintechnische Produkte
industryName: Gesundheitswesen
subsectorName: Hochentwickelte medizinische Geräte
country: Deutschland
countryName: Deutschland

Kontakt

name: Markus Georgi
phone: +49-6172-608-2485
fax: +49-6172-608-2488
email: ir-fre@fresenius.com
irWebSite: https://www.fresenius.com/de/investoren

Adresse

street: Else-Kröner-Straße 1
city: D-61352 Bad Homburg
phone: +49-6172-608-0
webSite: www.fresenius.de
email: pr-fre@fresenius.com

Finanzen (kurz)

year: 2021 cash: 2764.0000
balanceSheetTotal: 71962.0000 liabilities: 42674.0000
totalShareholdersEquity: 18998.0000 sales: 37520.0000
bankLoans: 4158.0000 investment: 124.0000
incomeBeforeTaxes: 3652.0000 netIncome: 1818.0000
cashFlow: 927.0000 employees: 316078
currencyID: 1 units: 1000000
currency: EUR
year: 2022 cash: 2749.0000
balanceSheetTotal: 76415.0000 liabilities: 44197.0000
totalShareholdersEquity: 20415.0000 sales: 40840.0000
investment: 187.0000 incomeBeforeTaxes: 2814.0000
netIncome: 2117.0000 employees: 316918
currencyID: 1 units: 1000000
currency: EUR
year: 2023 cash: 2562.0000
balanceSheetTotal: 45284.0000 liabilities: 25633.0000
totalShareholdersEquity: 18999.0000 sales: 22299.0000
investment: 118.0000 incomeBeforeTaxes: 715.0000
netIncome: 353.0000 employees: 193865
currencyID: 1 units: 1000000
currency: EUR

Finanzen (kurz)

year: 2021
cash: 2764.0000
balanceSheetTotal: 71962.0000
liabilities: 42674.0000
totalShareholdersEquity: 18998.0000
sales: 37520.0000
bankLoans: 4158.0000
investment: 124.0000
incomeBeforeTaxes: 3652.0000
netIncome: 1818.0000
cashFlow: 927.0000
employees: 316078
currencyID: 1
units: 1000000
currency: EUR
year: 2022
cash: 2749.0000
balanceSheetTotal: 76415.0000
liabilities: 44197.0000
totalShareholdersEquity: 20415.0000
sales: 40840.0000
investment: 187.0000
incomeBeforeTaxes: 2814.0000
netIncome: 2117.0000
employees: 316918
currencyID: 1
units: 1000000
currency: EUR
year: 2023
cash: 2562.0000
balanceSheetTotal: 45284.0000
liabilities: 25633.0000
totalShareholdersEquity: 18999.0000
sales: 22299.0000
investment: 118.0000
incomeBeforeTaxes: 715.0000
netIncome: 353.0000
employees: 193865
currencyID: 1
units: 1000000
currency: EUR

Finanzen (ausführlich)

year: 2022 units: 1000000
balanceSheetTotal: 76415.0000 cash: 2749.0000
currentAssets: 18279.0000 fixedAssets: 58136.0000
liabilities: 13658.0000 nonCurrentLiabilities: 30539.0000
totalLiabilitiesEquity: 76415.0000 provisions: 2802.0000
totalShareholdersEquity: 20415.0000 employees: 316918
property: 12919.0000 intangibleAssets: 4399.0000
longTermInvestments: 0.0000 inventories: 4833.0000
accountsReceivable: 7008.0000 accountsPayable: 2070.0000
liabilitiesTotal: 44197.0000 longTermDebt: 24727.0000
shortTermDebt: 856.0000 minorityInterests: 11803.0000
sales: 40840.0000 netIncome: 2117.0000
operatingResult: 3321.0000 incomeInterest: -507.0000
investments: 867.0000 incomeTaxes: 697.0000
costGoodsSold: 30115.0000 grossProfit: 10725.0000
minorityInterestsProfit: -745.0000 revenuePerEmployee: 128866.1420
cashFlow: 4198.0000 cashFlowInvesting: -2607.0000
cashFlowFinancing: -1604.0000 accountingStandard: IFRS
equityRatio: 26.7160 debtEquityRatio: 274.3081
liquidityI: 20.1274 liquidityII: 71.4380
netMargin: 5.1836 grossMargin: 26.2610
cashFlowMargin: 10.2791 ebitMargin: 8.1317
ebitdaMargin: 0.0000 preTaxROE: 13.7840
preTaxROA: 3.6825 roe: 10.3698
roa: 2.7704 netIncomeGrowth: 16.4466
revenuesGrowth: 8.8486 taxExpenseRate: 24.7690
equityTurnover: 2.0005 epsBasic: 2.4400
epsBasicGrowth: -25.1534 incomeBeforeTaxes: 2814.0000
priceEarningsRatioCompany: 10.7582 priceCashFlowRatio: 3.5219
dividendYield: 3.5048 bookValuePerShare: 36.2458
marketCap: 14784978521.2500 earningsYield: 9.2952
pegRatio: -0.4277 cashFlowPerShare: 7.4533
netAssetsPerShare: 57.2015 priceBookValueRatio: 0.7242
dividendsPerShare: 0.9200 priceEarningsRatio: 6.9839
netEarningsPerShare: 3.7586 currency: EUR
year: 2023 units: 1000000
balanceSheetTotal: 45284.0000 cash: 2562.0000
currentAssets: 12520.0000 fixedAssets: 32764.0000
liabilities: 9330.0000 nonCurrentLiabilities: 16303.0000
totalLiabilitiesEquity: 45284.0000 provisions: 7029.0000
totalShareholdersEquity: 18999.0000 employees: 193865
property: 8964.0000 intangibleAssets: 2531.0000
longTermInvestments: 3500.0000 inventories: 2517.0000
accountsReceivable: 3673.0000 accountsPayable: 1488.0000
liabilitiesTotal: 25633.0000 longTermDebt: 11457.0000
shortTermDebt: 2375.0000 minorityInterests: 652.0000
sales: 22299.0000 netIncome: 353.0000
operatingResult: 1143.0000 incomeInterest: -416.0000
investments: 661.0000 incomeTaxes: 477.0000
costGoodsSold: 17241.0000 grossProfit: 5058.0000
minorityInterestsProfit: 115.0000 revenuePerEmployee: 115023.3410
cashFlow: 4456.0000 cashFlowInvesting: -3187.0000
cashFlowFinancing: -1377.0000 accountingStandard: IFRS
equityRatio: 41.9552 debtEquityRatio: 138.3494
liquidityI: 27.4598 liquidityII: 66.8274
netMargin: 1.5830 grossMargin: 22.6826
cashFlowMargin: 19.9830 ebitMargin: 5.1258
ebitdaMargin: 0.0000 preTaxROE: 3.7634
preTaxROA: 1.5789 roe: 1.8580
roa: 0.7795 netIncomeGrowth: -83.3255
revenuesGrowth: -45.3991 taxExpenseRate: 66.7133
equityTurnover: 1.1737 epsBasic: -1.0500
epsBasicGrowth: -143.0328 incomeBeforeTaxes: 715.0000
priceCashFlowRatio: 3.5771 bookValuePerShare: 33.7318
marketCap: 15939614939.1000 earningsYield: -3.7102
cashFlowPerShare: 7.9114 netAssetsPerShare: 34.8894
priceBookValueRatio: 0.8390 priceEarningsRatio: 45.1547
netEarningsPerShare: 0.6267 currency: EUR
year: 2024 priceCashFlowRatio: 3.1549
bookValuePerShare: 33.7318 marketCap: 14058402433.9200
earningsYield: -4.2067 pegRatio: 0.1662
cashFlowPerShare: 7.9114 netAssetsPerShare: 33.7318
priceBookValueRatio: 0.7400 priceEarningsRatio: 39.8255
netEarningsPerShare: 0.6267 currency: EUR

Finanzen (ausführlich)

year: 2022
units: 1000000
balanceSheetTotal: 76415.0000
cash: 2749.0000
currentAssets: 18279.0000
fixedAssets: 58136.0000
liabilities: 13658.0000
nonCurrentLiabilities: 30539.0000
totalLiabilitiesEquity: 76415.0000
provisions: 2802.0000
totalShareholdersEquity: 20415.0000
employees: 316918
property: 12919.0000
intangibleAssets: 4399.0000
longTermInvestments: 0.0000
inventories: 4833.0000
accountsReceivable: 7008.0000
accountsPayable: 2070.0000
liabilitiesTotal: 44197.0000
longTermDebt: 24727.0000
shortTermDebt: 856.0000
minorityInterests: 11803.0000
sales: 40840.0000
netIncome: 2117.0000
operatingResult: 3321.0000
incomeInterest: -507.0000
investments: 867.0000
incomeTaxes: 697.0000
costGoodsSold: 30115.0000
grossProfit: 10725.0000
minorityInterestsProfit: -745.0000
revenuePerEmployee: 128866.1420
cashFlow: 4198.0000
cashFlowInvesting: -2607.0000
cashFlowFinancing: -1604.0000
accountingStandard: IFRS
equityRatio: 26.7160
debtEquityRatio: 274.3081
liquidityI: 20.1274
liquidityII: 71.4380
netMargin: 5.1836
grossMargin: 26.2610
cashFlowMargin: 10.2791
ebitMargin: 8.1317
ebitdaMargin: 0.0000
preTaxROE: 13.7840
preTaxROA: 3.6825
roe: 10.3698
roa: 2.7704
netIncomeGrowth: 16.4466
revenuesGrowth: 8.8486
taxExpenseRate: 24.7690
equityTurnover: 2.0005
epsBasic: 2.4400
epsBasicGrowth: -25.1534
incomeBeforeTaxes: 2814.0000
priceEarningsRatioCompany: 10.7582
priceCashFlowRatio: 3.5219
dividendYield: 3.5048
bookValuePerShare: 36.2458
marketCap: 14784978521.2500
earningsYield: 9.2952
pegRatio: -0.4277
cashFlowPerShare: 7.4533
netAssetsPerShare: 57.2015
priceBookValueRatio: 0.7242
dividendsPerShare: 0.9200
priceEarningsRatio: 6.9839
netEarningsPerShare: 3.7586
currency: EUR
year: 2023
units: 1000000
balanceSheetTotal: 45284.0000
cash: 2562.0000
currentAssets: 12520.0000
fixedAssets: 32764.0000
liabilities: 9330.0000
nonCurrentLiabilities: 16303.0000
totalLiabilitiesEquity: 45284.0000
provisions: 7029.0000
totalShareholdersEquity: 18999.0000
employees: 193865
property: 8964.0000
intangibleAssets: 2531.0000
longTermInvestments: 3500.0000
inventories: 2517.0000
accountsReceivable: 3673.0000
accountsPayable: 1488.0000
liabilitiesTotal: 25633.0000
longTermDebt: 11457.0000
shortTermDebt: 2375.0000
minorityInterests: 652.0000
sales: 22299.0000
netIncome: 353.0000
operatingResult: 1143.0000
incomeInterest: -416.0000
investments: 661.0000
incomeTaxes: 477.0000
costGoodsSold: 17241.0000
grossProfit: 5058.0000
minorityInterestsProfit: 115.0000
revenuePerEmployee: 115023.3410
cashFlow: 4456.0000
cashFlowInvesting: -3187.0000
cashFlowFinancing: -1377.0000
accountingStandard: IFRS
equityRatio: 41.9552
debtEquityRatio: 138.3494
liquidityI: 27.4598
liquidityII: 66.8274
netMargin: 1.5830
grossMargin: 22.6826
cashFlowMargin: 19.9830
ebitMargin: 5.1258
ebitdaMargin: 0.0000
preTaxROE: 3.7634
preTaxROA: 1.5789
roe: 1.8580
roa: 0.7795
netIncomeGrowth: -83.3255
revenuesGrowth: -45.3991
taxExpenseRate: 66.7133
equityTurnover: 1.1737
epsBasic: -1.0500
epsBasicGrowth: -143.0328
incomeBeforeTaxes: 715.0000
priceCashFlowRatio: 3.5771
bookValuePerShare: 33.7318
marketCap: 15939614939.1000
earningsYield: -3.7102
cashFlowPerShare: 7.9114
netAssetsPerShare: 34.8894
priceBookValueRatio: 0.8390
priceEarningsRatio: 45.1547
netEarningsPerShare: 0.6267
currency: EUR
year: 2024
priceCashFlowRatio: 3.1549
bookValuePerShare: 33.7318
marketCap: 14058402433.9200
earningsYield: -4.2067
pegRatio: 0.1662
cashFlowPerShare: 7.9114
netAssetsPerShare: 33.7318
priceBookValueRatio: 0.7400
priceEarningsRatio: 39.8255
netEarningsPerShare: 0.6267
currency: EUR